“Synthetic biology is one of the most exciting and rapidly growing scientific areas.”
Scientific institutions from countries across the globe have come together to launch a new alliance to help develop synthetic biology.
The Global Alliance of Biofoundries (GBA) brings together 16 institutions from countries including the UK, US, Japan, Singapore, China, Australia, Denmark and Canada.
The London DNA Foundry, based at Imperial College London (@imperialcollege), is one of the leading founders of the new Global Alliance.
The GBA will share knowledge, infrastructure and expertise to tackle global challenges and play a central role in the ‘synthetic biology revolution’ and the transition to a new global bio-based economy.
Synthetic biology – a rapidly growing research area and new industry – brings principles from biology and engineering together to design and construct new biological entities such as enzymes, genetic circuits, and cells or redesign existing biological systems – used for important applications like new therapeutics, sustainable biomaterials, biosensors, bioenergy and food production.
Biofoundries are being established at universities and institutions around the world to provide the infrastructure and technology to both accelerate academic research and develop the new synthetic biology industry.
Examples of research include manufacturing new vaccines and developing living therapeutics, designing and building DNA, creating biofuels, and making bioplastics more effectively and sustainably.
Professor Paul Freemont, Co-Director of the London DNA Foundry based at Imperial, co-organiser of the Kobe meeting and lead author of the publication, said: “The Global Alliance of Biofoundries is a major step to accelerating the synthetic biology industry worldwide.
“It will provide researchers around the globe with the tools and technologies to exploit fundamental research and will support new industries to develop.
“Modern biology will be led by these foundries which will benefit society and drive the transition to a global bioeconomy.”
Professor Richard Kitney, Co-Director of the UK Innovation and Knowledge Centre for Synthetic Biology, SynbiCITE said: “Synthetic biology is one of the most exciting and rapidly growing scientific areas.
“The last five years has seen a number of Biofoundries set up around the world and this new Alliance will bring them together to collaborate and tackle global challenges.”
Professor Paul Freemont and Professor Richard Kitney are both lead speakers at SynbiTECH 2019 (June 24-25th, QEII Centre, London) – and as a reader of Bio Market Insights, you can claim a ticket for just £600! Visit the e-bookings page and go to title ‘Special Rate’ which has the corresponding code: SPECIALRATE to activate this saving. One ticket per reader.*